Katagiri Norika, Sakai Ryutaro, Izutsu Takashi, Kawana Hiromasa, Sugino Shigekazu, Kido Kanta
Department of Anesthesiology, Kanagawa Dental University Hospital, Yokosuka, Kanagawa, Japan.
Department of Oral and Maxillofacial Surgery, Yamagata Prefectural Central Hospital, Yamagata City, Yamagata, Japan.
Anesth Prog. 2020 Sep 1;67(3):158-163. doi: 10.2344/anpr-67-01-06.
Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders of the gastrointestinal tract including ulcerative colitis (UC) and Crohn's disease. Pain management can be challenging in patients with IBD because there are limitations on the use of analgesics. Use of nonsteroidal anti-inflammatory drugs is not recommended in patients with IBD because there is risk of relapse of IBD and an overall increase in disease activity. Opioids, although frequently used for treating severe acute pain, can have additional risks and complications in patients with IBD such as ileus, toxic megacolon, and narcotic bowel syndrome. Furthermore, little information is available in the literature on pain management in these patients undergoing noncolorectal surgery. This report describes 2 patients with UC in whom postoperative pain following oral and maxillofacial surgery was managed by intravenous patient-controlled analgesia with pentazocine. Apart from the development of acute dystonia in 1 case that was likely due to the use of droperidol for prevention of postoperative nausea and vomiting, postoperative pain was well controlled by pentazocine in both patients without any complications or UC exacerbations.
炎症性肠病(IBD)是一组胃肠道慢性炎症性疾病,包括溃疡性结肠炎(UC)和克罗恩病。IBD患者的疼痛管理具有挑战性,因为在镇痛药的使用上存在限制。不建议IBD患者使用非甾体类抗炎药,因为存在IBD复发和疾病活动总体增加的风险。阿片类药物虽然常用于治疗严重急性疼痛,但在IBD患者中可能会有额外的风险和并发症,如肠梗阻、中毒性巨结肠和麻醉性肠综合征。此外,关于这些接受非结直肠手术患者的疼痛管理,文献中几乎没有相关信息。本报告描述了2例UC患者,他们在口腔颌面手术后的疼痛通过静脉注射喷他佐辛进行患者自控镇痛来管理。除了1例可能因使用氟哌利多预防术后恶心和呕吐而发生急性肌张力障碍外,喷他佐辛在两名患者中均很好地控制了术后疼痛,且无任何并发症或UC病情加重。